Picture of hVIVO logo

HVO hVIVO Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for hVIVO, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2020
December 31st
C2021
December 31st
2022
December 31st
C2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSInterim ReportARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-11.20.277-0.36511.113.3
Depreciation
Non-Cash Items2.07-1.614.93-2.27-3.28
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital11.2-0.478.495.65-3.23
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities4.170.7651617.210.3
Capital Expenditures-1.09-0.739-1.36-5.18-2.46
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items2.281.181.8
Sale/Maturity of Investment
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities1.18-0.739-1.36-4-0.66
Financing Cash Flow Items-3.63-1.190.635-0.127-0.063
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities13-3.52-1.83-4.7-2.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash18.2-3.5112.88.537.21